Certain cancer cells stave off their death with help from a particular molecule in a protein involved in the body’s immune system response, a research team at Rush University Medical Center has found.
Representatives of the Rush system and Little Company of Mary Hospital and Health Care Centers have signed a non-binding letter of intent for LCMH to join the Rush system.
Rush is among the first hospitals in the country to implant a spinal cord stimulation device that automatically adjusts electrical impulses according to body position shifts — another opioid alternative for chronic pain.
Four of six people with paralyzing spinal cord injuries who were treated with a new cell therapy have recovered a significant level of movement on at least one side, new study results show.
Rush University Medical Center will invest more than $6 million over the next three years in organizations that are working to revitalize neighborhoods on the West Side of Chicago.
An annual study has ranked Rush University Medical Center fourth among 107 leading academic medical centers in the U.S., up from fifth last year.
Rush now offers pediatric primary care services at our new offsite clinic.
Rush University Medical Center is developing a comprehensive program that will provide opioid screening and treatment for patients identified as opioid users on the medical and surgical inpatient units and will expand to outpatient screening.
Rush has been named one of the best hospitals to work for by indeed.com and topped the list of nurse.org’s Best Hospitals in Illinois for Nurses.
High levels of a protein known as suPAR, which has been shown to be a marker and likely cause of kidney damage, is as reliably predictive in children as in adults, according to recently published study results.